Thursday, 9 December, 2021

Diabetes may become a global plague by ’30

Bangladesh will move up to seventh place

  • Staff Correspondent
  • 17 November, 2021 12:00 AM
  • Print news

Public and private sectors must engage in raising social awareness about diabetes for a better and healthy life, said experts.

Addressing a free diabetes screening camp at the Directorate General of Drug Administration (DGDA) in the capital’s Mohakhali on Tuesday, they also emphasized the importance of carrying out mass screening for diabetes during the Covid-19 pandemic, said a press release.

DGDA and Denmark-based company Novo Nordisk jointly organised the camp marking World Diabetes Day.

DGDA Director General Major General Md Mahbubur Rahman was present as the chief guest while Assistant Directors, Md. Aziulla and Md. Ayub Hossain, were the special guest. Apart from them, Tanbir Sajib, Director of Commercial Affairs at Novo Nordisk Bangladesh and other officials were present.

According to information from the World Diabetes Forum, diabetes may become a global plague by 2030 while Bangladesh will move up to seventh place in terms of number of patients.

At the programme, Major General Md. Mahbubur Rahman said that the health sector's capacity in Bangladesh was observed during the Covid-19 outbreak when doctors and nurses served as frontline responders.

He applauded doctors' contribution to preventing the spread of non-infectious disorders such as diabetes as a result of the coronavirus effects.

The DGDA chief said quality medicines for diabetes are now available, but active lifestyle is essential for a diabetic patient in addition to treatment.

The speakers said an initiative should be taken to keep diabetes under control. The next decade will be critical to tackling diabetes if necessary measures are not taken immediately, they said.

This year's theme for World Diabetes Day is "Access to diabetes care: If not now, when?". This year also marks the 100th anniversary of the invention of insulin.

The government has taken an initiative to provide insulin among Type-1 diabetic patients free of cost.